<DOC>
	<DOCNO>NCT02885649</DOCNO>
	<brief_summary>This pilot phase 0 trial study well enzalutamide work surgery treat patient kidney cancer . Androgens type hormone produce body may cause kidney tumor grow . Anti-hormone therapy , enzalutamide , may lessen amount androgen produce body keep kidney tumor grow .</brief_summary>
	<brief_title>Enzalutamide Before Surgery Treating Patients With Kidney Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To investigate effect neoadjuvant enzalutamide clear cell renal cell carcinoma ( ccRCC ) . OUTLINE : Patients receive enzalutamide orally ( PO ) daily 90 day absence disease progression unacceptable toxicity . Patients undergo partial radical nephrectomy . After completion study treatment , patient follow every 3 month .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>Clinical T1N0M0 ( = &lt; 7 cm ) renal mass measure crosssectional imaging ( compute tomography [ CT ] magnetic resonance image [ MRI ] ) Biopsy proven ccRCC Tumor androgen receptor ( AR ) express &gt; = 4580 copies/ug ribonucleic acid ( RNA ) Can provide informed consent Adequate hepatic function ( &gt; = 1.5 x upper limit normal [ ULN ] ; patient 's Gilbert 's disease exclude ) Adequate renal function ( estimate glomerular filtration rate [ GFR ] &gt; 40mL/min ) No evidence metastatic disease baseline imaging ( chest xray [ CXR ] chest CT , abdominal CT MRI ) Eastern Cooperative Oncology Group ( ECOG ) performance status = &lt; 2 Prior use androgen deprivation include enzalutamide Pregnant woman woman child bear age willing use two ( 2 ) form contraception treatment enzalutamide six ( 6 ) month treatment Men must use adequate method contraception least 3 month treatment engage sexual activity female child bearing age Known hypersensitivity enzalutamide History unprovoked deep vein thrombosis/pulmonary embolism ( DVT/PE ) past twelve ( 12 ) month Inability stop anticoagulants/antiplatelet therapy perioperatively History seizure condition may predispose seizure ( e.g. , prior cortical stroke significant brain trauma ) History loss consciousness transient ischemic attack within twelve ( 12 ) month enrollment Any unstable , serious coexist medical condition include limited myocardial infarction , coronary bypass surgery , unstable angina , cardiac arrhythmia , clinically evident congestive heart failure , cerebrovascular accident within twelve ( 12 ) month prior screen Known suspect brain metastasis active leptomeningeal disease Current use exogenous testosterone Retroperitoneal/hilar adenopathy concern locally advanced disease Metastatic RCC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>